Skip to main content
Matthew Rivara, MD, Nephrology, Seattle, WA

Matthew B Rivara MD


Associate Professor of Medicine

Join to view full profile
  • 325 9th AveSeattle, WA 98104

  • Phone+1 206-744-8990

  • Fax+1 206-744-5087

Dr. Rivara is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Washington
    University of WashingtonFellowship, Nephrology, 2012 - 2015
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2009 - 2012
  • Harvard Medical School
    Harvard Medical SchoolClass of 2009

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2026 - 2027
  • WA State Medical License
    WA State Medical License 2012 - 2027
  • MA State Medical License
    MA State Medical License 2011 - 2014
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Nephrology
    American Board of Internal Medicine Nephrology

Publications & Presentations

PubMed

Journal Articles

  • Fostering Innovation in Symptom Management Among Hemodialysis Patients  
    Jennifer E Flythe, Matthew Bertrand Rivara, Rajnish Mehrotra, Steven Darrow Weisbord, Journal of the American Society of Nephrology

Press Mentions

  • Nighttime Masked Uncontrolled Hypertension Tied to Poor Outcomes in CKD
    Nighttime Masked Uncontrolled Hypertension Tied to Poor Outcomes in CKDJune 6th, 2022
  • Standardized Approach to HTN May Reduce Disparities in Care
    Standardized Approach to HTN May Reduce Disparities in CareJanuary 12th, 2022
  • Patiromer Prolongs Spironolactone Use Regardless of Diabetes Status
    Patiromer Prolongs Spironolactone Use Regardless of Diabetes StatusJuly 15th, 2021

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: